Physician profile
Timothy May
NPI 1215609979
$1,894.03
in general payments reported to CMS, 2019-2025
18 companies · $986 in 2025
The $986 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $363 · 2023: $179 · 2024: $256 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Food and Beverage | $620.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $800.00 | 2025 | |
| Convatec INC. | $249.30 | 2023-2025 | |
| Janssen Biotech, INC. | $224.38 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $129.79 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.30 | 2022 | |
| Astellas Pharma US INC | $66.10 | 2023-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $51.89 | 2022-2023 | Provenge |
| Laborie Medical Technologies Corp. | $41.69 | 2025 | |
| Boston Scientific Corporation | $37.26 | 2024 | Ams 700 |
| Calyxo, INC. | $29.47 | 2024-2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $27.86 | 2022 | |
| Abc Home Medical Supply, INC. | $25.72 | 2025 | |
| Amgen INC. | $22.21 | 2022 | |
| Sumitomo Pharma America, INC. | $17.53 | 2023 | Gemtesa |
| Astrazeneca Pharmaceuticals Lp | $15.95 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.43 | 2023 | Yonsa |
| Tolmar Pharmaceuticals, INC. | $13.73 | 2022 | |
| Olympus America INC. | $13.42 | 2024 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.